Log In
Print
BCIQ
Print
Print this Print this
 

Tozadenant (SYN115)

Also known as: SYN-115

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionSelective adenosine A2A receptor (ADORA2A) antagonist
Molecular Target Adenosine A2A receptor (ADORA2A)
Mechanism of ActionAdenosine A2A receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation

Partner

Biotie Therapies Corp.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today